verapamil has been researched along with Infections, Staphylococcal in 4 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ciprofloxacin was predominantly (65%) distributed in the cytosol." | 1.32 | Influence of P-glycoprotein and MRP efflux pump inhibitors on the intracellular activity of azithromycin and ciprofloxacin in macrophages infected by Listeria monocytogenes or Staphylococcus aureus. ( Carryn, S; Seral, C; Tulkens, PM; Van Bambeke, F, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eissa, IH | 1 |
| Mohammad, H | 2 |
| Qassem, OA | 1 |
| Younis, W | 1 |
| Abdelghany, TM | 1 |
| Elshafeey, A | 1 |
| Abd Rabo Moustafa, MM | 1 |
| Seleem, MN | 3 |
| Mayhoub, AS | 3 |
| Elsebaei, MM | 1 |
| Abouf, M | 1 |
| Abutaleb, NS | 2 |
| Hegazy, YA | 1 |
| Ghiaty, A | 1 |
| Chen, L | 1 |
| Zhang, J | 1 |
| Malwal, SR | 1 |
| Oldfield, E | 1 |
| Shahin, IG | 1 |
| Alhashimi, M | 1 |
| Kassab, AE | 1 |
| Mohamed, KO | 1 |
| Taher, AT | 1 |
| Seral, C | 1 |
| Carryn, S | 1 |
| Tulkens, PM | 1 |
| Van Bambeke, F | 1 |
4 other studies available for verapamil and Infections, Staphylococcal
| Article | Year |
|---|---|
Diphenylurea derivatives for combating methicillin- and vancomycin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Caenorhabditis elegans; Carbanilides; Drug Resistance, Bacterial; Me | 2017 |
Alkynyl-containing phenylthiazoles: Systemically active antibacterial agents effective against methicillin-resistant Staphylococcus aureus (MRSA).
Topics: Alkynes; Animals; Anti-Bacterial Agents; Half-Life; Methicillin-Resistant Staphylococcus aureus; Mic | 2018 |
Evaluation of N-phenyl-2-aminothiazoles for treatment of multi-drug resistant and intracellular Staphylococcus aureus infections.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Humans; | 2020 |
Influence of P-glycoprotein and MRP efflux pump inhibitors on the intracellular activity of azithromycin and ciprofloxacin in macrophages infected by Listeria monocytogenes or Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Bin | 2003 |